Related Experiment Video
Updated: Sep 4, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Human Papillomavirus Vaccinations During the COVID-19 Pandemic in Middle Schools in the Rio Grande Valley of Texas
Ana M Rodriguez1, Thuy Quynh N Do1, Maria L Jibaja-Weiss1
1Ana M. Rodriguez is with the Department of Obstetrics & Gynecology, University of Texas Medical Branch, Galveston. Thuy Quynh N. Do is with the Department of Preventive Medicine and Population Health, University of Texas Medical Branch. Maria L. Jibaja-Weiss is with the Department of Pediatrics, Section of Hematology-Oncology, Dan L Duncan Comprehensive Cancer Center, Office of Outreach and Health Disparities, Baylor College of Medicine, Houston, TX. Lu Chen and Yong-Fang Kuo are with the Office of Biostatistics, Preventive Medicine and Population Health, University of Texas Medical Branch. Kathleen M. Schmeler is with the Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston. Jane R. Montealegre is with the Baylor College of Medicine-Houston School of Health Professions, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine.
Abstract:
This quasi-experimental study (a community-based, physician-led human papillomavirus [HPV] education campaign and school-based vaccination program) followed 6481 students at eight Pharr-San Juan-Alamo Independent School District (Rio Grande Valley, Texas) middle schools between August 2016 and March 2021. We describe the successes and challenges experienced during the COVID-19 pandemic. HPV vaccine initiation and completion rates increased 1.29-fold and 1.47-fold, respectively, between June 2019 and March 2021. Between March 2020 and March 2021, 268 HPV vaccine doses were provided through 24 school-based interventions. Our program continued successes seen in increasing HPV vaccination rates and reducing possible HPV-associated cancers. (Am J Public Health. 2022;112(9):1269-1272. https://doi.org/10.2105/AJPH.2022.306970).
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Humoral Immune Responses
Sexually Transmitted Infections

